AI製藥站上風口！ETF怎麼投？

新浪基金

昨天

　　9月16日，AI製藥領域三筆重磅合作同日落地：

　　1、字節跳動孵化的Anew Labs完成2.9億美元首輪外部孖展正式獨立。

　　2、諾和諾德與Anthropic合作將Claude大模型引入新藥研發核心流程。

　　3、禮來旗下TuneLab攜手金斯瑞打通AI設計後的規模化溼實驗驗證。

　　⛓️ AI製藥產業化加速，投資工具關注👇🏻

　　🧬 AI製藥含量近70%

　　🏥 港股通醫療ETF華寶#159137

　　🧬 AI+CRO、AI醫療

　　🏥 醫療ETF華寶#512170

　　🧬 AI+Biotech

　　💊 港股通創新藥ETF華寶#520880

　　🧬 AI+Biotech

　　💊 藥ETF華寶#562050

　　🐲 投龍頭 · 選華寶

　　⚠️ 市場有風險投資須謹慎！

MACD金叉信號形成，這些股漲勢不錯！

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/news/2668692149"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2668692149\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2668692149?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-09-17 19:06","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2668692149","market":"us","top_or_hot":-1,"title":"AI製藥站上風口！ETF怎麼投？","media":"新浪基金","content":"<html><body><div>\n<p>　　9月16日，AI製藥領域三筆重磅合作同日落地：</p>\n<p>　　1、字節跳動孵化的Anew Labs完成2.9億美元首輪外部孖展正式獨立。</p>\n<p>　　2、諾和諾德與Anthropic合作將Claude大模型引入新藥研發核心流程。</p>\n<p>　　3、禮來旗下TuneLab攜手<a href=\"https://laohu8.com/S/01548\">金斯瑞</a>打通AI設計後的規模化溼實驗驗證。</p>\n<p>　　⛓️ AI製藥產業化加速，投資工具關注👇🏻</p>\n<p>　　🧬 AI製藥含量近70%</p>\n<p>　　🏥 港股通醫療ETF<a href=\"https://laohu8.com/S/300741\">華寶</a>#159137</p>\n<p>　　🧬 AI+CRO、AI醫療</p>\n<p>　　🏥 醫療ETF華寶#512170</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 <a href=\"https://laohu8.com/S/520880\">港股通創新藥ETF華寶</a>#520880</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 藥ETF華寶#562050</p>\n<p>　　🐲 投龍頭 · 選華寶</p>\n<p>　　⚠️ 市場有風險 投資須謹慎！</p>\n<div>\n<span>MACD金叉信號形成，這些股漲勢不錯！</span>\n</div>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AI製藥站上風口！ETF怎麼投？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAI製藥站上風口！ETF怎麼投？\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新浪基金</strong><span class=\"h-time small\">2026-09-17 19:06</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<p>　　9月16日，AI製藥領域三筆重磅合作同日落地：</p>\n<p>　　1、字節跳動孵化的Anew Labs完成2.9億美元首輪外部孖展正式獨立。</p>\n<p>　　2、諾和諾德與Anthropic合作將Claude大模型引入新藥研發核心流程。</p>\n<p>　　3、禮來旗下TuneLab攜手<a href=\"https://laohu8.com/S/01548\">金斯瑞</a>打通AI設計後的規模化溼實驗驗證。</p>\n<p>　　⛓️ AI製藥產業化加速，投資工具關注👇🏻</p>\n<p>　　🧬 AI製藥含量近70%</p>\n<p>　　🏥 港股通醫療ETF<a href=\"https://laohu8.com/S/300741\">華寶</a>#159137</p>\n<p>　　🧬 AI+CRO、AI醫療</p>\n<p>　　🏥 醫療ETF華寶#512170</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 <a href=\"https://laohu8.com/S/520880\">港股通創新藥ETF華寶</a>#520880</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 藥ETF華寶#562050</p>\n<p>　　🐲 投龍頭 · 選華寶</p>\n<p>　　⚠️ 市場有風險 投資須謹慎！</p>\n<div>\n<span>MACD金叉信號形成，這些股漲勢不錯！</span>\n</div>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.sina.com.cn/money/fund/etf/2026-09-17/doc-iniscvfx3581124.shtml\">新浪基金</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CHAT","symbol_name":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","start_time":0,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-17/doc-iniscvfx3581124.shtml","article_id":"2668692149","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2668692149","pubTimestamp":1789643160,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"9月16日，AI製藥領域三筆重磅合作同日落地：1、字節跳動孵化的Anew Labs完成2.9億美元首輪外部融資正式獨立。AI製藥產業化加速，投資工具關注 AI製藥含量近70% 港股通醫療ETF華寶#159137 AI+CRO、AI醫療 醫療ETF華寶#512170 AI+Biotech 港股通創新藥ETF華寶#520880 AI+Biotech 藥ETF華寶#562050 投龍頭 · 選華寶 市場有風險 投資須謹慎！","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK1574":"生物医药B类股","BK4550":"红杉资本持仓","BK4588":"碎股","QTOC":"Innovator Growth Accelerated Plus ETF - October","BK1191":"制药","BK4585":"ETF&股票定投概念","ARTY":"ISHARES FUTURE AI & TECH ETF","01477":"欧康维视生物-B","AIPO":"Defiance AI and Power Infrastructure ETF","AGIX":"通用人工智能 ETF-AGIX","FDN":"First Trust Dow Jones Internet I","VTHR":"Vanguard Russell 3000 ETF"},"translate_title":"AI-powered pharmaceuticals are on the rise! How do I invest in ETFs?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHAT":1.5,"AIPO":1.5,"VTHR":1.5,"01477":1.5,"AGIX":1.5,"ARTY":1.5,"QTOC":1.5,"FDN":1.5},"content_text":"9月16日，AI製藥領域三筆重磅合作同日落地：\n　　1、字節跳動孵化的Anew Labs完成2.9億美元首輪外部融資正式獨立。\n　　2、諾和諾德與Anthropic合作將Claude大模型引入新藥研發核心流程。\n　　3、禮來旗下TuneLab攜手金斯瑞打通AI設計後的規模化濕實驗驗證。\n　　⛓️ AI製藥產業化加速，投資工具關注👇🏻\n　　🧬 AI製藥含量近70%\n　　🏥 港股通醫療ETF華寶#159137\n　　🧬 AI+CRO、AI醫療\n　　🏥 醫療ETF華寶#512170\n　　🧬 AI+Biotech\n　　💊 港股通創新藥ETF華寶#520880\n　　🧬 AI+Biotech\n　　💊 藥ETF華寶#562050\n　　🐲 投龍頭 · 選華寶\n　　⚠️ 市場有風險 投資須謹慎！\n\nMACD金叉信號形成，這些股漲勢不錯！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}